<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: InvaGen Pharmaceuticals, Inc.; Proposal To Withdraw Approval of an Abbreviated New Drug Application for Trandolapril Tablets; Opportunity for a Hearing</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: InvaGen Pharmaceuticals, Inc.; Proposal To Withdraw Approval of an Abbreviated New Drug Application for Trandolapril Tablets; Opportunity for a Hearing</h1>
    <p class="timestamp">Published: 2019-10-28 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration's (FDA or Agency) Center for Drug Evaluation and Research (CDER) is proposing to withdraw approval of an abbreviated new drug application (ANDA) for trandolapril tablets and is announcing an opportunity for the holder of the ANDA to request a hearing on this proposal. The basis for the proposal is that the holder of the ANDA has repeatedly failed to submit the required data to support a finding of bioequivalence for this ANDA.</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2019-23461</p>
    <p><strong>Publication Date:</strong> 2019-10-28</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2019/10/28/2019-23461/invagen-pharmaceuticals-inc-proposal-to-withdraw-approval-of-an-abbreviated-new-drug-application-for">https://www.federalregister.gov/documents/2019/10/28/2019-23461/invagen-pharmaceuticals-inc-proposal-to-withdraw-approval-of-an-abbreviated-new-drug-application-for</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2019-23461</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
